Despite rapid advances in molecular diagnostics and targeted therapeutics, clinical adoption of precision medicine by frontline providers, and adoption into standard clinical practice workflows, has been relatively slow. Questions about clinical utility, poor payer reimbursement, and access to targeted therapies are some of the major hurdles that have hampered clinical adoption of personalized medicine. Despite these challenges, academic medical centers, integrated delivery networks, and community care centers have invested in personalized medicine programs in an ongoing search for innovative care models to deliver improved patient outcomes and achieve economic gains.

This panel will discuss three personalized medicine programs, their structure, successes in achieving and demonstrating value, and their value metrics, as examples of clinical implementation strategies and improved outcomes associated with personalized medicine.

Ability Level: Intermediate

Session ID: 21126